Hans Edgar Bishop, CEO & President at Juno Therapeutics, Inc. (JUNO), sold 44,000 shares at $33.00 ($1.5M) on 2016-09-27, disclosed to the SEC on 2016-09-29.
Open-market sale of $1.5M JUNO by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $2.6M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $8.9M | — | Filing → |